(19)

(11)

EP 4 815 982 A2

(12)

(88) Date of publication A3: 14.08.2025 (43) Date of publication: 07.10.2026 Bulletin 2026/41 (21) Application number: 24898702.6 (22) Date of filing: 27.11.2024

(51) International Patent Classification (IPC):  A61K 39/12(2006.01) C07K 7/54(2006.01) A61P 31/22(2006.01) A61K 47/14(2017.01) A61K 39/245(2006.01) C07K 7/08(2006.01) A61K 38/12(2006.01) (52) Cooperative Patent Classification (CPC): A61K 38/00; C07K 14/005; C12N 2710/16622; C12N 2710/16633 (86) International application number: PCT/US2024/057627 (87) International publication number: WO 2025/117649 (05.06.2025 Gazette 2025/23)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 28.11.2023 US 202363603426 P (71) Applicant: Red Queen Therapeutics, Inc. Cambridge, MA 02142 (US)	(72) Inventor: HERCE, Henry David Cambridge, Massachusetts 02142 (US) (74) Representative: Cooley (UK) LLP  22 Bishopsgate London EC2N 4BQ London EC2N 4BQ (GB)